• Ridaforolimus (Deforolimus): Selective mTOR Inhibitor in Can

  2026-05-13

  Ridaforolimus (Deforolimus, MK-8669) is a potent, selective mTOR inhibitor with nanomolar activity. It inhibits phosphorylation of mTOR pathway targets and shows broad antiproliferative effects across diverse cancer cell lines. APExBIO offers Ridaforolimus with rigorous quality controls for research applications.

• Cefodizime as a Precision Tool for AMR Surveillance and Micr

  2026-05-12

  Explore the advanced scientific profile of Cefodizime, a third-generation cephalosporin antibiotic, as a precision tool for antimicrobial resistance (AMR) surveillance and microbiological assay design. Discover unique insights on its immunomodulatory effects and evidence-based protocol parameters for research applications.

• (1S,3R)-RSL3: Precision Ferroptosis Induction in RAS-Driven

  2026-05-12

  Explore how (1S,3R)-RSL3, a potent glutathione peroxidase 4 inhibitor, enables advanced and selective ferroptosis induction in RAS-driven cancer research. This article delivers a deep, translational analysis informed by recent bioinformatics insights and practical assay considerations.

• KX2-391 Dihydrochloride: Bridging Oncology, Virology & Neuro

  2026-05-11

  Explore the multifaceted profile of KX2-391 dihydrochloride as a dual-action Src kinase and tubulin inhibitor, HBV transcription inhibitor, and botulinum neurotoxin A antagonist. This article offers new insights on practical assay design, translational challenges, and cross-domain applications, uniquely grounded in the latest research.

• HyperTrap Heparin HP Column: Precision Purification in Stemn

  2026-05-11

  The HyperTrap Heparin HP Column, leveraging HyperChrom Heparin HP Agarose, delivers unmatched resolution for isolating critical biomolecules—including growth factors and nucleic acid enzymes—even from complex cancer models. Its robust design and chemical stability streamline advanced workflows, empowering researchers to dissect cancer stemness pathways with confidence and reproducibility.

• Phosphatase Inhibitor Cocktail 1: Precision in Phosphorylati

  2026-05-10

  Phosphatase Inhibitor Cocktail 1 (100X in DMSO) enables robust protein phosphorylation preservation in cell and tissue lysates. Its targeted inhibition of alkaline and serine/threonine phosphatases protects labile phosphoproteins, facilitating accurate phosphoproteomic and signaling pathway analyses. APExBIO's K1012 kit is validated for reproducibility in Western blot workflows.

• Sulfo-NHS-Biotin: Precision Protein Labeling in Cell Studies

  2026-05-09

  Sulfo-NHS-Biotin stands out as an amine-reactive, water-soluble biotinylation reagent for selective cell surface protein labeling without membrane permeation. This article details optimized workflows, troubleshooting strategies, and experimental design insights for deploying Sulfo-NHS-Biotin in affinity-based and immunoprecipitation assays, with a translational lens on host-pathogen research.

• CTCF’s Role in Centromere Integrity and Mitotic Fidelity Unv

  2026-05-08

  This study establishes CTCF as a critical maintainer of centromere structure and mitotic accuracy in human cells. Using a rapid degron system, the authors demonstrate that CTCF loss disrupts chromosome alignment and nuclear morphology, revealing mechanistic insights relevant for cell cycle and cancer research.

• Technical Application Guide: Anti-HMGB1 Rabbit Monoclonal An

  2026-05-08

  The Anti-HMGB1 Rabbit Monoclonal Antibody (SKU MA3057) addresses the need for specific, high-affinity detection of HMGB1 protein in human, mouse, and rat samples using Western blot, immunohistochemistry, and flow cytometry. It is not validated for diagnostic or therapeutic purposes and is intended strictly for research workflows involving chromatin protein detection.

• Mac-1 Deficiency Reduces Cardiac Remodeling via Macrophage M

  2026-05-07

  This study demonstrates that Mac-1 deficiency significantly ameliorates cardiac dysfunction and pathological remodeling under pressure overload by inhibiting macrophage infiltration and M1 polarization. The findings identify Mac-1 as a promising target for therapeutic intervention in heart failure and highlight the importance of immune signaling pathways in cardiac disease.

• Morin: Applied Workflows and Troubleshooting in Disease Mode

  2026-05-07

  Morin (2-(2,4-dihydroxyphenyl)-3,5,7-trihydroxy-4H-chromen-4-one) is a high-purity natural flavonoid that excels as both a mechanistic probe in diabetes and neuroprotection studies and a fluorescent chelator for aluminum detection. This guide translates leading-edge research and protocol insights into actionable workflows, troubleshooting strategies, and advanced use-cases for Morin in translational disease research.

• Polymyxin B (sulfate): Reliable Solutions for Advanced Lab A

  2026-05-06

  This article addresses critical laboratory challenges in cell-based infection and immunomodulation assays, illustrating how Polymyxin B (sulfate) (SKU C3090) from APExBIO offers reliable, data-backed performance. Through real-world scenarios, we clarify protocol optimization, product selection, and data interpretation, ensuring reproducibility and scientific rigor for biomedical researchers.

• ALDOB K87 Lactylation and Mitochondrial Dynamics in Pulmonar

  2026-05-06

  This article reviews new evidence that ALDOB K87 lactylation drives mitochondrial fission and metabolic reprogramming in pulmonary hypertension by recruiting DRP1 to mitochondria. These insights clarify mechanisms of smooth muscle cell proliferation and suggest new avenues for therapeutic intervention.

• Disulfiram (SKU A4015): Reliable Tool for Apoptosis & Protea

  2026-05-05

  This scenario-driven article explores how Disulfiram (SKU A4015) addresses persistent challenges in cell viability, proliferation, and synthetic lethality assays. By integrating recent evidence and best-practice protocols, it demonstrates how APExBIO’s Disulfiram offers reproducible, data-backed solutions for cancer research workflows.

• Verteporfin (CL 318952): Mechanotransduction, Chemoresistanc

  2026-05-05

  Explore Verteporfin (CL 318952) as more than a photosensitizer—delve into its role in mechanotransduction, chemoresistance, and advanced photodynamic therapy assays. Unique analysis links the tumor microenvironment’s mechanics with Verteporfin’s action, offering new directions for age-related macular degeneration and drug resistance research.

10249 records 1/684 page Next 12345 下5页 Last page